🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Trento
Clinical trial register · Italy

Clinical Trials in Trento, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6830 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:52 UTC
6830
Studies in scope
all four open statuses
4109
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2849 Bologna 1313 Roma 1277 Naples 984 Rome 980
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Pfizer3 Santa Chiara Hospital3 Amgen2 Astellas Pharma Global Development, Inc.2 Azienda Sanitaria Universitaria Integrata del Trentino2
Site location
Milan2849 Bologna1313 Roma1277 Naples984 Rome980
All 483 locations
Target enrolment
to

Trials with a site in Trento

37 of 6830 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
AI-driven Processing and Analysis of Glioma Imaging Data
NCT07703761Glioma, Glioma (Diagnosis)
Università degli Studi di Trento
Observational
700
Trento
2026-01-21
Recruiting
Functional Impact of Acute Respiratory Viral Infections in Older Adults
NCT07388173Respiratory Infections in Old Age
University Hospital, Grenoble
Observational
1,600
Bari, Catanzaro, Rovigo, Sanremo, Torino, Trento, Trieste, Venice
2026-01-15
Recruiting
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
NCT07213674Metastatic Castration-resistant Prostate Cancer
DrugsXaluritamig·Cabazitaxel·Abiraterone acetate·Docetaxel
Amgen
Phase 3
750
Foggia, Milan, Modena, Orbassano, Peschiera del Garda, Rozzano, Trento
2025-11-28
Recruiting
Prognostic Role of Macular Neovascular Membrane Subtype in Pneumatic Displacement of Macular Hemorrhages
NCT07427160AMD - Age-Related Macular Degeneration
Marco Mazzola
Observational
60
Trento
2025-10-15
Recruiting
Targeting prEssure-Muscle-index to Avoid Ventilatory Over-Assistance During Pressure Support Ventilation
NCT06921655Acute Hypoxemic Respiratory Failure, Mechanical Ventilation Complication
Centre for Medical Sciences
Not applicable
36
Trento
2025-10-08
Recruiting
TMS-related Measures as Biomarker of Cognitive Impairment in PD
NCT06835595Parkinson Disease
Azienda Sanitaria Universitaria Integrata del Trentino
Not applicable
52
Trieste, Sterzing, Trento
2025-09-10
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
NCT07005154Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
DrugsASP5541·Abiraterone acetate·Prednisolone·Prednisone
Astellas Pharma Global Development, Inc.
Phase 2
218
Milan, Roma, Trento
2025-08-19
Active, closed
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
NCT06991556Metastatic Hormone-sensitive Prostate Cancer
DrugsJSB462·Abiraterone·Enzalutamide
Novartis Pharmaceuticals
Phase 2
168
Asti, Padova, Trento, Orbassano, Verona
2025-07-07
Not yet open
Proton Radiosurgery for the Treatment of Malignant Ventricular Tachyarrhythmias
NCT06769451Ventricular Arrhythmia, Ventricular Tachycardia (V-Tach)
Azienda Sanitaria Universitaria Integrata del Trentino
Not applicable
21
Trento
2025-02
Not yet open
Personalized Virtual Environments for Managing Responsive Behaviors in Cognitively Impaired Patients: a Feasibility Study
NCT06693193Cognitive Impairment, Dementia
Fondazione Bruno Kessler
Not applicable
10
Trento
2025-01
Active, closed
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)
NCT06691984Metastatic Castration-resistant Prostate Cancer
DrugsXaluritamig·Cabazitaxel·Abiraterone·Enzalutamide
Amgen
Phase 3
707
Foggia, Gallipoli, Genova, Milan, Orbassano, Trento
2024-12-09
Recruiting
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
NCT06629779Metastatic Castration-Resistant Prostate Cancer
DrugsMevrometostat·Xtandi·Enzalutamide
Pfizer
Phase 3
900
Meldola, Rome, Rozzano, Cremona, Milan, Naples, Terni, Trento
2024-10-22
Recruiting
Clinical-ultrasonographic Assessment of Pulmonary Emphysema
NCT06533371Emphysema, Pulmonary Emphysema
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not applicable
1,628
Acquaviva delle Fonti, Naples, Rome, Trento
2024-09-04
Recruiting
Prenatal Ultrasonographic Assessment of Fetal Thyroid in Patients With Thyroid Pathology
NCT06788821Thyroid Disease Pregnancy
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
440
Bologna, Trento
2024-06-12
Recruiting
International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia
NCT05759299Airway Complication of Anesthesia
University of Turin, Italy
Observational
10,500
Monza, Orbassano, Torino, Milan, Trento
2024-01-15
Active, closed
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
NCT06046222Eosinophilic Granulomatosis With Polyangiitis, Churg-Strauss Syndrome
NS Pharma, Inc.
Phase 2
45
Milan, Roma, Trento, Verona
2023-12-20
Recruiting
Study on the Incidence of Malignant Neoplasms in Patients With Parkinson's Disease and Heterozygous Mutation of the GBA Gene
NCT06814431Idiopathic Parkinson's Disease (PD)
Azienda USL Reggio Emilia - IRCCS
Observational
3,000
Brindisi, Milan, Reggio Emilia, Trento
2023-11-23
Recruiting
Rescue of Nephrons With ALE.F02 (RENAL-F02)
NCT06047171Glomerulonephritis Rapidly Progressive
DrugsCyclophosphamid·Rituximab
Alentis Therapeutics AG
Phase 2
80
Bergamo, Florence, Milan, Rome, Trento
2023-09-07
Active, closed
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
NCT05696717Symptomatic Neurogenic Orthostatic Hypotension, MSA - Multiple System Atrophy
Theravance Biopharma
Phase 3
102
Bologna, Milan, Rome, Salerno, Terni, Trento, Tricase
2023-06-27
Recruiting
Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer
NCT06783127Prostate Cancer, Castrate Resistant Prostate Cancer, BRCA Mutation
DrugOlaparib
Santa Chiara Hospital
Observational
3,000
Naples, Trento
2023-01-01
Recruiting
CardioPulmonary Resuscitation With Argon (CPAr) Trial
NCT05482945Cardiac Arrest, Out-Of-Hospital, Cardiac Arrest With Successful Resuscitation
Mario Negri Institute for Pharmacological Research
Phase 2
120
Genova, Monza, Milan, Parma, Pordenone, Reggio Emilia, Roma, Trento
2022-05-30
Recruiting
PROton Versus Photon Therapy for Esophageal Cancer - a Trimodality Strategy
NCT05055648Esophageal Cancer, Radiotherapy, Side Effect, Proton Therapy
University of Aarhus
Phase 3
396
Milan, Pavia, Trento
2022-05-01
Active, closed
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
NCT05288166Prostatic Neoplasms, Neoplasm Metastasis, Urogenital Neoplasms, Physiological Effects of Drugs
DrugsAbiraterone·Prednisolone·Abemaciclib·Prednisone
Eli Lilly and Company
Phase 3
925
Meldola, Rome, Milan, Castelfranco Veneto, Terni, Trento
2022-04-14
Active, closed
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
NCT05132582HER2 Positive Breast Cancer
DrugsPerjeta·Tucatinib·Herceptin·Pertuzumab
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Naples, Genoa, Monza (MB), Catania (CT), Torrette, Trento, Livorno, Prato
2022-03-07
Active, closed
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
NCT04821622Prostate Cancer
DrugsTalazoparib·Enzalutamide
Pfizer
Phase 3
599
Bologna, Cremona, Meldola, San Giovanni Rotondo, Naples, Aviano, Trento, Arezzo
2021-05-12
Active, closed
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC
NCT04446117Metastatic Prostate Cancer, Prostate Adenocarcinoma
DrugsZytiga·Xtandi·Abiraterone·Abiraterone acetate
Exelixis
Phase 3
575
Meldola, Rozzano, Sondrio, Trento, Ancona, Florence, Milan, Parma
2020-10-19
Active, closed
Pre- Versus Sub-pectoral Implant-based Breast Reconstruction After Skin-sparing Mastectomy or Nipple-sparing Mastectomy OPBC-02PREPEC
NCT04293146Breast Reconstruction, Implant-Based Breast Reconstruction (IBBR)
University Hospital, Basel, Switzerland
Not applicable
382
Roma, Trento
2020-07-28
Recruiting
Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening Ischemia
NCT06277362Peripheral Arterial Disease, Critical Limb-Threatening Ischemia, Diabetic Foot
EndoCore Lab s.r.l.
Observational
50
Ancona, Belluno, Cesena, Conegliano, Naples, Reggio Emilia, Trento, Perugia
2020-01-31
Recruiting
PRostate Cancer Plasma Integrative Multi-modal Evaluation
NCT06981377Metastatic Prostate Cancer
Santa Chiara Hospital
Observational
800
Meldola, Orbassano, Padova, Trento
2019-05-07
Active, closed
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
NCT03395197mCRPC
Pfizer
Phase 3
1,054
Bologna, Cremona, Meldola, Terni, Trento, Orbassano, Naples
2017-12-18
Active, closed
Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate Cancer
NCT03230734Metastatic Castration-resistant Prostate Cancer
DrugsXofigo·Docetaxel
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2
70
Meldola, Lecce, Rozzano, Rionero in Vulture, Trento, Orbassano, Negrar, Aviano
2017-09-01
Recruiting
Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease
NCT02986516Chordoma
Italian Sarcoma Group
Not applicable
100
Milan, Bologna, Florence, Pavia, Pisa, Rome, Trento
2017-03-16
Active, closed
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
NCT02960022Prostate Cancer
DrugsLeuprolide Acetate·Abiraterone acetate·Enzalutamide·Prednisone
Astellas Pharma Global Development, Inc.
Phase 2
900
Faenza (RA), Arezzo, Candiolo, Cremona, Forlì, Roma, Toscana, Trento
2016-12-22
Recruiting
Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients
NCT06473259Prostate Cancer, Hormone Sensitive Prostate Cancer, Metastatic Tumor
DrugsElacestrant·Apalutamide·Abiraterone acetate·Darolutamide
Santa Chiara Hospital
Observational
3,000
Orbassano, Padova, Trento
2016-12-16
Active, closed
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
NCT02308085Early Breast Cancer
ETOP IBCSG Partners Foundation
Not applicable
518
Prato, Carpi, Trento, Castellanza, Aviano, Biella, Bolzano, Genova
2014-12-04
Active, closed
An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
NCT01357668Juvenile Idiopathic Arthritis
Bristol-Myers Squibb
Observational
800
Florence, Genova, Naples, Padova, Trento
2013-01-30
Recruiting
International Registry of Accidental Hypothermia
NCT06200285Accidental Hypothermia
University Hospital, Geneva
Observational
500
Bergamo, Bolzano, Trento
2008-10-01
Rows per page Showing 1–37 of 37
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-italy/city/trento

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,830 studies in total at the last sync on 26 Sep 2026, 19:52 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 37 of those studies with a site in Trento.

How many clinical trials are recruiting in Trento?

21 of the 37 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:52 UTC sync. A further 2 have not yet opened recruitment, 14 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Trento), 37 studies
PhaseStudiesRecruitingShare
Observational121132.4%
Phase 310327%
Not applicable8421.6%
Phase 27318.9%

Most active sponsors

Lead sponsors with the most studies (Trento)
Lead sponsorStudiesRecruiting
Pfizer31
Santa Chiara Hospital33
Amgen21
Astellas Pharma Global Development, Inc.21
Azienda Sanitaria Universitaria Integrata del Trentino21
Alentis Therapeutics AG11
Azienda USL Reggio Emilia - IRCCS11
Bristol-Myers Squibb10
Centre for Medical Sciences11
Eli Lilly and Company10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.